Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Amicus Therapeutics stock have a consensus rating of "Buy" and an average price target of $29.79, which forecasts a 110.08% increase in the stock price over the next year. The lowest target is $11 and the highest is $108.

Price Target: $29.79 (+110.08%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$11	$29.79	$17	$108
Change	-22.43%	+110.08%	+19.89%	+661.64%

Analyst Ratings

The average analyst rating for Amicus Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	3	2
Buy	4	4	4	4	4	3
Hold	2	2	1	1	1	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	9	9	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gil Blum Needham	Needham	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 19, 2025
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy → Hold Downgrades $21 → $15	Buy → Hold	Downgrades	$21 → $15	+2.26%	Dec 19, 2025
Samantha Semenkow Citigroup	Citigroup	Strong Buy Initiates $17	Strong Buy	Initiates	$17	+19.89%	Dec 17, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $18 → $19	Buy	Maintains	$18 → $19	+33.99%	Nov 6, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Hold Maintains $9 → $11	Hold	Maintains	$9 → $11	-22.43%	Nov 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

641.80M

Increased by 21.49%

from 528.30M

Revenue Next Year

758.95M

Increased by 18.25%

from 641.80M

EPS This Year

-0.02

from -0.18

EPS Next Year

0.27

from -0.02

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	260.89M	305.51M	329.23M	399.36M	528.30M	641.80M	758.95M
Revenue Growth	43.16%	17.11%	7.76%	21.30%	32.29%	21.49%	18.25%
EPS	-1.07	-0.92	-0.82	-0.51	-0.18	-0.02	0.27
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	51.76
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	667.3M	794.0M
Avg	641.8M	759.0M
Low	610.8M	718.5M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	26.3%	23.7%
Avg	21.5%	18.3%
Low	15.6%	12.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	0.01	0.34
Avg	-0.02	0.27
Low	-0.06	0.22

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.